A £48 million wound care research centre is set to launch in East Yorkshire through a partnership led by the University of Hull and key industry stakeholders. The Wound Innovation Centre (WIC) will focus on chronic wound research and commercial development of treatments, addressing a condition that currently costs the NHS over £8 billion annually.
The project is backed by £16 million from the UK Research Partnership Investment Fund and an additional £32 million from partners including Reckitt and Polaroid Therapeutics. The WIC will operate across the University of Hull campus and Castle Hill Hospital, creating a joint research and clinical infrastructure.
The centre will serve as a national hub for skin and wound research, designed to accelerate discovery, clinical testing, and commercial application. With involvement from academia, healthcare providers, and private industry, it aims to accelerate the development and market introduction of solutions, particularly for antimicrobial resistance and hard-to-heal wounds.
The partnership aligns with Reckitt’s broader R&D interests in skin health and complements its consumer healthcare brands.
